A new publication involving MOTS-c was released on September 14, 2026. The paper, titled "Mitokines as bioenergetic stress signals in cardiovascular disease: mitochondrial communication, endocrine adaptation, and translational implications," appears in the Journal of Bioenergetics and Biomembranes.
MOTS-c remains classified as an unapproved research compound. This entry represents a new publication event, and the title indicates the paper addresses mitokines as bioenergetic stress signals within cardiovascular disease, mitochondrial communication, and endocrine adaptation, with translational implications discussed.
No findings, results, or conclusions from the publication are detailed here beyond its title, journal, and publication date. Readers interested in the full scope of the discussion should consult the original source directly for methodology and any reported outcomes.
For further background on MOTS-c, including its classification and general research context, readers can consult the compound overview.